Literature DB >> 18298665

Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies.

Emiliano Biasini1, M Esa Seegulam, Brianna N Patti, Laura Solforosi, Andrea Z Medrano, Heather M Christensen, Assunta Senatore, Roberto Chiesa, R Anthony Williamson, David A Harris.   

Abstract

The key event in the pathogenesis of prion diseases is the conformational conversion of the normal prion protein (PrP) (PrP(C)) into an infectious, aggregated isoform (PrP(Sc)) that has a high content of beta-sheet. Historically, a great deal of effort has been devoted to developing antibodies that specifically recognize PrP(Sc) but not PrP(C), as such antibodies would have enormous diagnostic and experimental value. A mouse monoclonal IgM antibody (designated 15B3) and three PrP motif-grafted monoclonal antibodies (referred to as IgG 19-33, 89-112, and 136-158) have been previously reported to react specifically with infectious PrP(Sc) but not PrP(C). In this study, we extend the characterization of these four antibodies by testing their ability to immunoprecipitate and immunostain infectious and non-infectious aggregates of wild-type, mutant, and recombinant PrP. We find that 15B3 as well as the motif-grafted antibodies recognize multiple types of aggregated PrP, both infectious and non-infectious, including forms found in brain, in transfected cells, and induced in vitro from purified recombinant protein. These antibodies are exquisitely selective for aggregated PrP, and do not react with soluble PrP even when present in vast excess. Our results suggest that 15B3 and the motif-grafted antibodies recognize structural features common to both infectious and non-infectious aggregates of PrP. Our study extends the utility of these antibodies for diagnostic and experimental purposes, and it provides new insight into the structural changes that accompany PrP oligomerization and prion propagation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298665     DOI: 10.1111/j.1471-4159.2008.05306.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Authors:  Toshiya Kubota; Yuta Hamazoe; Shuhei Hashiguchi; Daisuke Ishibashi; Kazuyuki Akasaka; Noriyuki Nishida; Shigeru Katamine; Suehiro Sakaguchi; Ryota Kuroki; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

2.  Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated September 17, 2008.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.

Authors:  Roberto Chiesa; Pedro Piccardo; Emiliano Biasini; Bernardino Ghetti; David A Harris
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

4.  PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity.

Authors:  David Mengel; Wei Hong; Grant T Corbett; Wen Liu; Alexandra DeSousa; Laura Solforosi; Cheng Fang; Matthew P Frosch; John Collinge; David A Harris; Dominic M Walsh
Journal:  Brain Res       Date:  2018-12-26       Impact factor: 3.252

5.  Characterization of conformation-dependent prion protein epitopes.

Authors:  Hae-Eun Kang; Chu Chun Weng; Eri Saijo; Vicki Saylor; Jifeng Bian; Sehun Kim; Laylaa Ramos; Rachel Angers; Katie Langenfeld; Vadim Khaychuk; Carla Calvi; Jason Bartz; Nora Hunter; Glenn C Telling
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 6.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Authors:  Wen-Quan Zou; Xiaochen Zhou; Jue Yuan; Xiangzhu Xiao
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

7.  Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.

Authors:  Larry H Stanker; Miles C Scotcher; Alice Lin; Jeffery McGarvey; Stanley B Prusiner; Robert Hnasko
Journal:  Hybridoma (Larchmt)       Date:  2012-10

8.  Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.

Authors:  Ru Sun; Ying Liu; He Zhang; Laura Manuelidis
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

9.  PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains.

Authors:  Eri Saijo; Andrew G Hughson; Gregory J Raymond; Akio Suzuki; Motohiro Horiuchi; Byron Caughey
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

10.  Immunopurification of pathological prion protein aggregates.

Authors:  Emiliano Biasini; Laura Tapella; Susanna Mantovani; Matteo Stravalaci; Marco Gobbi; David A Harris; Roberto Chiesa
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.